Structures by: Ravikumar K.
Total: 373
3-(2-chloroethyl)-2-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin- 1-ium chloride
C11H16ClN2O,Cl
Acta Crystallographica Section E (2006) 62, 9 o3730-o3731
a=6.609(5)Å b=10.340(8)Å c=18.473(14)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl 4-{4-[2-(dimethylamino)ethoxy]phenyl}-2,6-dimethyl-1,4-dihydropyridine- 3,5-dicarboxylate
C21H28N2O5
Acta Crystallographica Section E (2006) 62, 10 o4699-o4701
a=8.4072(5)Å b=11.2593(7)Å c=11.5788(7)Å
α=71.0360(10)° β=86.8400(10)° γ=84.2090(10)°
2-(2,6-diphenylpiperidine)ethan-1-ol
C19H23NO
Acta Crystallographica Section E (2006) 62, 12 o5390-o5392
a=11.7863(9)Å b=12.2482(9)Å c=12.8201(10)Å
α=95.0770(10)° β=107.6370(10)° γ=109.7680(10)°
4'-(4-Methoxyphenyl)-1'-methyl-5-diphenyl-5,6,7,8,9,10-hexahydro-1,3- cyclooctapyrimidino[2,3-b]thiazole-2-spiro-3'-pyrrolidine-2'-spiro-3''- 1H-indole-2'',3(2H,3''H)-dione
C36H36N4O3S
Acta Crystallographica Section E (2007) 63, 1 o129-o131
a=11.4459(19)Å b=12.085(2)Å c=13.612(2)Å
α=69.568(3)° β=65.586(3)° γ=71.038(3)°
4'-(4-Methoxyphenyl)-1'-methyl-5-diphenyl-5,6,7,8,9,10-hexahydro-1,3- cycloheptapyrimidino[2,3-b]thiazole-2-spiro-3'-pyrrolidine-2'-spiro-3''- 1H-indole-2'',3(2H,3''H)-dione
C35H34N4O3S
Acta Crystallographica Section E (2007) 63, 1 o132-o134
a=11.4338(7)Å b=11.9540(8)Å c=13.5843(11)Å
α=70.300(2)° β=65.1430(10)° γ=72.1790(10)°
Methyl 1'-(2-hydroxy-1,3-dioxo-2,3-dihydro-1H-indan-2-yl)-2-oxo-5',6',7',7a'- tetrahydrospiro[1H-indole-3,3'(2H,2'H)-1'H-pyrrolizine]-1'-carboxylate
C25H22N2O6
Acta Crystallographica Section E (2007) 63, 3 o1492-o1494
a=8.6659(6)Å b=8.6988(6)Å c=14.5841(11)Å
α=84.3890(10)° β=85.3730(10)° γ=76.4020(10)°
(3Z)-2-Benzyl-3-benzylidene-6-phenyl-2-azabicyclo[2.2.2]octan-5-one
C27H25NO
Acta Crystallographica Section E (2007) 63, 3 o1500-o1501
a=9.5155(7)Å b=17.6544(13)Å c=12.4242(9)Å
α=90.00° β=97.4640(10)° γ=90.00°
C15H7BrCl3FO
C15H7BrCl3FO
Acta Crystallographica Section E (2007) 63, 5 o2060-o2061
a=14.3752(9)Å b=11.3099(7)Å c=37.302(2)Å
α=90.00° β=90.00° γ=90.00°
(3aR,6S,6aR)-6-Benzyl-1-(4-bromophenyl)-5-tosyl-cis- perhydropyrrolo[3,4-b]pyrrole
C26H27BrN2O2S
Acta Crystallographica Section E (2007) 63, 5 o2228-o2229
a=20.9376(11)Å b=10.5821(6)Å c=11.0154(6)Å
α=90.00° β=90.00° γ=90.00°
2-Bromo-1-(2,4-dichloro-5-fluorophenyl)-3-phenylprop-2-en-1-one
C15H8BrCl2FO
Acta Crystallographica Section E (2007) 63, 5 o2309-o2310
a=6.5423(8)Å b=14.3317(16)Å c=7.8040(9)Å
α=90.00° β=93.284(2)° γ=90.00°
Ethyl 3-(2-chloro-5-methyl-3-pyridyl)-3-hydroxy-2-methylenepropanoate
C12H14ClNO3
Acta Crystallographica Section E (2007) 63, 5 o2188-o2189
a=10.8209(5)Å b=10.4195(5)Å c=11.2937(5)Å
α=90.00° β=97.8450(10)° γ=90.00°
1-{2-[(4-Nitrobenzylidene)amino]phenyl}-3-phenylthiourea
C20H16N4O2S
Acta Crystallographica Section E (2007) 63, 5 o2226-o2227
a=7.2705(6)Å b=11.0178(9)Å c=12.0137(9)Å
α=84.7760(10)° β=85.6750(10)° γ=75.4050(10)°
5-Benzylidene-1-phenyl-2'',3''-dihydropiperidine-3-spiro-2'-pyrrolizidine- 3'-spiro-3''-1H-indole-4,2''-dione
C32H31N3O2
Acta Crystallographica Section E (2007) 63, 5 o2211-o2212
a=8.7120(4)Å b=20.5711(10)Å c=14.9467(7)Å
α=90.00° β=99.3220(10)° γ=90.00°
1,3,7-Trimethylxanthenium 2,4,6-trinitrophenolate
C8H11N4O2,C6H2N3O7
Acta Crystallographica Section E (2007) 63, 5 o2495-o2496
a=8.2996(10)Å b=9.0014(11)Å c=23.210(3)Å
α=90.00° β=91.474(2)° γ=90.00°
3-[3-(4-Ethoxyphenyl)-1-phenyl-1H-pyrazol-4-yl]-4-nitro-2,5- diphenylisoxazolidine
C32H28N4O4
Acta Crystallographica Section E (2007) 63, 5 o2216-o2217
a=13.2463(7)Å b=10.0112(6)Å c=20.9518(12)Å
α=90.00° β=101.6880(10)° γ=90.00°
4-Nitro-2-[(phenylhydrazono)methyl]phenol
C13H11N3O3
Acta Crystallographica Section E (2007) 63, 5 o2224-o2225
a=12.8167(13)Å b=8.2176(8)Å c=12.5848(12)Å
α=90.00° β=113.068(2)° γ=90.00°
1-(Benzylideneacetyl)-2-phenyl-1,2,3,5,10,10a-hexahydro- 1<i>H</i>-pyrrolo[1,2-<i>b</i>]isoquinoline-3-spiro-3'(2'<i>H</i>)-1<i>H</i>- indol-3'-one
C34H28N2O2
Acta Crystallographica Section E (2007) 63, 8 o3490-o3490
a=19.301(4)Å b=14.725(3)Å c=18.583(4)Å
α=90.00° β=90.00° γ=90.00°
Tetraaqua(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylato- κ^2^N^3^,O)cobalt(II) 2.5-hydrate
C5H10CoN2O8,2.5(H2O)
Acta Crystallographica Section E (2007) 63, 12 m2887-m2888
a=20.8700(19)Å b=17.1153(16)Å c=7.3375(7)Å
α=90.00° β=90.00° γ=90.00°
1-Vinyl-1H-indole-3-carbaldehyde
C11H9NO
Acta Crystallographica Section E (2008) 64, 6 o1163
a=8.3200(5)Å b=8.1490(5)Å c=13.1620(7)Å
α=90.00° β=99.9520(10)° γ=90.00°
Bis(<i>S</i>-benzylisothiouronium) tetrachloridozincate(II)
2(C8H11N2S),Cl4Zn2
Acta Crystallographica Section E (2008) 64, 6 m848-m849
a=15.2135(11)Å b=6.4475(5)Å c=23.9277(18)Å
α=90.00° β=95.3680(10)° γ=90.00°
1-[4-oxo-4-(2,4,6-trimethoxy­phenyl)but-1-yl]pyrrolidinium hydrochloride
C17H26NO4,Cl
Acta Crystallographica Section E (2006) 62, 11 o4832-o4834
a=7.0333(5)Å b=29.534(2)Å c=9.1257(6)Å
α=90.00° β=104.7570(10)° γ=90.00°
4'-(4-Chlorophenyl)-1'-methyl- indan-2-spiro-2'-pyrrolidine-3'-spiro-2''(1''H)-carbazole-1,3,3''(4''H)-trione
C30H23ClN2O3
Acta Crystallographica Section E (2006) 62, 11 o5075-o5077
a=10.2044(6)Å b=11.5646(7)Å c=11.8815(7)Å
α=64.8560(10)° β=82.5990(10)° γ=72.0730(10)°
Biphenyl
C19H17BrO6
Acta Crystallographica Section E (2007) 63, 9 o3763-o3763
a=7.0122(5)Å b=8.9766(6)Å c=15.3539(10)Å
α=75.073(10)° β=89.510(10)° γ=85.010(10)°
Cedrelone butyrolactone
C26H30O6
Acta Crystallographica Section E (2007) 63, 9 o3806-o3807
a=12.6858(9)Å b=13.1117(9)Å c=13.3530(10)Å
α=90.000° β=90.000° γ=90.000°
3-(4-Chlorophenyl)-7-methyl-4-(4-methylphenyl)-1-oxa-2,7- diazaspiro[4.5]dec-2-en-10-one
C21H21ClN2O2
Acta Crystallographica Section E (2008) 64, 2 o398-o398
a=11.4585(8)Å b=16.1132(11)Å c=10.1038(7)Å
α=90.00° β=90.00° γ=90.00°
3-[(E)-2,4-Dichlorobenzylidene]-1-methylpiperidin-4-one
C13H13Cl2NO
Acta Crystallographica Section E (2008) 64, 2 o520-o520
a=12.2013(9)Å b=8.5901(6)Å c=12.6391(9)Å
α=90.00° β=92.9970(10)° γ=90.00°
4'-Amino-2,2''-dioxo-2,2'',3,3''-tetrahydro-1H-indole-3-spiro-1'-cyclopent- 3'-ene-2'-spiro-3''-1H-indole-3',5',5'-tricarbonitrile dihydrate
C22H12N6O2,2(H2O)
Acta Crystallographica Section E (2008) 64, 2 o501-o502
a=17.1850(16)Å b=8.9849(9)Å c=13.3275(13)Å
α=90.00° β=90.00° γ=90.00°
1'-Phenyl-6'-thiacycloheptane-1-spiro-2'-perhydropyrrolizine-3'-spiro-3''- indoline-2,2''-dione
C25H26N2O2S
Acta Crystallographica Section E (2008) 64, 2 o488-o488
a=8.9846(10)Å b=10.3564(11)Å c=12.8124(14)Å
α=80.147(2)° β=71.012(2)° γ=67.497(2)°
3-(4-Methoxyphenyl)-6-(phenylsulfonyl)perhydro-1,3- thiazolo[3',4':1,2]pyrrolo[4,5-c]pyrrole
C21H24N2O3S2
Acta Crystallographica Section E (2008) 64, 2 o515-o515
a=14.5533(8)Å b=8.3319(5)Å c=16.8828(9)Å
α=90.00° β=98.9230(10)° γ=90.00°
3-(4-Methoxyphenyl)-1',6,6-trimethyl-4,5,6,7-tetrahydrospiro[1-benzofuran- 2,3'(3H,2'H)-1H-indole]-2',4-dione
C24H22ClNO3
Acta Crystallographica Section E (2007) 63, 2 o1034-o1036
a=13.9638(8)Å b=13.8490(8)Å c=22.1754(13)Å
α=90.00° β=100.8510(10)° γ=90.00°
Spiro[4.3']oxindole-spiro[5.2"]cyclooctanone-6-phenyl- thiapyrrolizidine
C26H28N2O2S
Acta Crystallographica Section E (2007) 63, 2 o852-o854
a=9.0901(6)Å b=10.5013(7)Å c=12.7508(8)Å
α=79.8650(10)° β=71.5040(10)° γ=68.5680(10)°
1-[5-(4-Fluorophenyl)-1,2-oxazol-3-ylmethyl]-2-nitroiminoimidazolidine
C13H12FN5O3
Acta Crystallographica Section E (2006) 62, 9 o3850-o3851
a=7.8575(6)Å b=15.6860(12)Å c=11.4098(9)Å
α=90.00° β=107.9450(10)° γ=90.00°
1,8-Bis(3-formyl-2-oxido-5-methylbenzyl}-1,8-diaza-4,11-diazoniacyclotetradecane chloroform solvate
C28H40N4O4,CHCl3
Acta Crystallographica Section E (2006) 62, 9 o3714-o3715
a=11.1366(5)Å b=11.2816(5)Å c=14.2124(7)Å
α=69.5640(10)° β=84.5590(10)° γ=67.1100(10)°
2,6-Diphenyl-1-propylpiperidine
C20H25N
Acta Crystallographica Section E (2006) 62, 9 o4169-o4171
a=5.6325(4)Å b=13.8274(11)Å c=10.7341(8)Å
α=90.00° β=99.1050(10)° γ=90.00°
Lamotrigine dimethylformamide sesquisolvate
C9H7Cl2N5,1.5C3H7NO
Acta Crystallographica Section E (2006) 62, 10 o4752-o4754
a=10.4444(13)Å b=10.9943(13)Å c=16.976(2)Å
α=83.637(2)° β=74.850(2)° γ=70.582(2)°
Palonosetron hydrochloride
C19H25ON2,Cl
Acta Crystallographica Section E (2007) 63, 3 o1404-o1406
a=7.4972(7)Å b=9.0288(8)Å c=25.045(2)Å
α=90.00° β=90.00° γ=90.00°
4-(2,4-Dichlorophenyl)-5-(N,N-diethylcarbamoyl)-6-methyl-3,4-dihydropyrimidine- 2(1H)-thione
C16H19Cl2N3OS
Acta Crystallographica Section E (2007) 63, 4 o1772-o1773
a=11.7548(11)Å b=14.4443(14)Å c=20.946(2)Å
α=90.00° β=90.00° γ=90.00°
Rizatriptan benzoate
C15H20N5,C7H5O2
Acta Crystallographica Section E (2007) 63, 4 o1958-o1960
a=8.7405(6)Å b=21.3242(15)Å c=22.2434(16)Å
α=90.00° β=90.00° γ=90.00°
Zolmitriptan
C16H21N3O2
Acta Crystallographica Section E (2007) 63, 4 o1774-o1776
a=9.0643(7)Å b=11.4220(9)Å c=14.6320(12)Å
α=90.00° β=90.00° γ=90.00°
Zolmitriptan.chloroform
C16H21N3O2,CHCl3
Acta Crystallographica Section E (2007) 63, 4 o1961-o1962
a=7.9987(6)Å b=12.8279(9)Å c=20.2396(14)Å
α=90.00° β=90.00° γ=90.00°
6-ethyl-1-(p-flurophenyl)-5-benzene sulfonyloctahydro-cis-\ pyrrolo[3,4-b]pyrrole
C20H23FN2O2S
Acta Crystallographica Section E (2007) 63, 5 o2057-o2059
a=7.8671(4)Å b=13.6413(7)Å c=17.4200(9)Å
α=90.00° β=90.00° γ=90.00°
2,3-Dibromo-3-(4-chlorophenyl)-1-(2,4-dichloro-5-fluorophenyl)propan-1-one
C15H8Br2Cl3FO
Acta Crystallographica Section E (2007) 63, 5 o2493-o2494
a=10.5292(10)Å b=10.5897(10)Å c=30.534(3)Å
α=90.00° β=91.111(2)° γ=90.00°
2-(Methoxycarbonyl)-3-phenylprop-2-enyl 3-hydroxynapthalene-2-carboxylate
C22H18O5
Acta Crystallographica Section E (2007) 63, 5 o2297-o2299
a=7.5053(7)Å b=22.468(2)Å c=10.7081(9)Å
α=90.00° β=106.1010(10)° γ=90.00°
3-(1,3-Benzodioxol-5-yl)-2-bromo-1-(2,4-dichloro-5-fluorophenyl)prop-2-en-1-one
C16H8BrCl2FO3
Acta Crystallographica Section E (2007) 63, 5 o2491-o2492
a=9.9442(6)Å b=13.9545(9)Å c=11.0593(7)Å
α=90.00° β=91.1300(10)° γ=90.00°
Ethyl 2-(1H-indol-3-yl)-5-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]- 4-nitro-3-(p-tolyl)pyrrolidine-2-carboxylate
C39H38N4O6
Acta Crystallographica Section E (2007) 63, 5 o2221-o2223
a=11.2689(8)Å b=35.612(2)Å c=8.8848(6)Å
α=90.00° β=99.7850(10)° γ=90.00°
1'-Nitro-2'-(3-nitrophenyl)-2',3',5',6',7',7a'-hexahydroindan-2-spiro- 3'-1'H-pyrrolizine-1,3-dione
C21H17N3O6
Acta Crystallographica Section E (2007) 63, 5 o2218-o2220
a=26.1766(15)Å b=8.1726(5)Å c=17.7838(10)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(Methylamino)-3-nitro-4H-chromen-4-yl]phenyl acetate
C18H16N2O5
Acta Crystallographica Section E (2007) 63, 5 o2300-o2302
a=23.7412(13)Å b=8.3846(5)Å c=16.1457(9)Å
α=90.00° β=96.4400(10)° γ=90.00°
4'-(4-Chlorophenyl)-1'-methylcycloheptane-1-spiro-3'-pyrrolidine-2'-spiro- 2''-indan-2,1'',3''-trione
C25H24ClNO3
Acta Crystallographica Section E (2007) 63, 5 o2230-o2232
a=9.3282(10)Å b=19.025(2)Å c=12.5249(14)Å
α=90.00° β=105.101(2)° γ=90.00°
2'-(2-Chlorophenyl)-1'-nitro-2',3',3a',4',5',6'-hexahydroindan-2-spiro- 3'-1'H-pyrrolizine-1,3-dione
C21H17ClN2O4
Acta Crystallographica Section E (2007) 63, 5 o2233-o2235
a=7.6022(5)Å b=9.7346(7)Å c=12.6386(9)Å
α=85.2960(10)° β=84.2000(10)° γ=86.5270(10)°
1'-Methyl-4'-phenyl-1H-indole-3-spiro-2'-pyrrolidine-3'-spiro-1''- cyclooctane-2(3H),2''-dione
C25H28N2O2
Acta Crystallographica Section E (2006) 62, 11 o4821-o4823
a=6.3359(5)Å b=17.3414(14)Å c=18.4066(15)Å
α=90.00° β=90.00° γ=90.00°
2-[[2-Chloro-5-(4-methoxyphenyl)pyridin-3-yl](hydroxy)methyl]acrylonitrile
C16H13ClN2O2
Acta Crystallographica Section E (2006) 62, 11 o5063-o5064
a=12.6478(11)Å b=12.8564(11)Å c=18.2165(15)Å
α=90.00° β=90.00° γ=90.00°
4'-(4-Chlorophenyl)-2'-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin- 2-yl]-1'-methyl-2-phenyl-spiro[1,3-oxazole-4(5H),3'-pyrrolidin]-5-one
C35H30ClN3O4
Acta Crystallographica Section E (2006) 62, 9 o4166-o4168
a=10.0409(10)Å b=13.2335(13)Å c=13.4951(13)Å
α=117.751(2)° β=94.976(2)° γ=98.865(2)°
2-(tosylamino)butan-1-ol
C11H17NO3S
Acta Crystallographica Section E (2006) 62, 10 o4454-o4455
a=6.4659(4)Å b=7.0150(5)Å c=14.2483(9)Å
α=101.7200(10)° β=97.9620(10)° γ=99.0150(10)°
(2S)-2-Benzyl-1-[(4R)-4-benzyl-2,2-dimethyl-1,3-oxazolan-3-yl]pent-4-en-1-one
C24H29NO2
Acta Crystallographica Section E (2006) 62, 10 o4755-o4757
a=10.0061(12)Å b=11.5146(14)Å c=18.602(2)Å
α=90.00° β=90.00° γ=90.00°
3'-Nitro-4'-phenylspiro[1H-indole-3,2'-pyrrolidin]-2-one
C18H17N3O3
Acta Crystallographica Section E (2006) 62, 11 o5072-o5074
a=11.8937(13)Å b=7.9224(9)Å c=17.5571(19)Å
α=90.00° β=97.299(2)° γ=90.00°
6-methoxy-1,3-benzoxazolin-2(3H)-one
C8H7NO3
Acta Crystallographica Section E (2006) 62, 12 o5950-o5952
a=12.4251(12)Å b=3.9154(4)Å c=16.0231(16)Å
α=90.00° β=108.796(2)° γ=90.00°
1'-Methyl-4'-phenylindan-2-spiro-2'-pyrrolidine-3'-spiro-1''-cyclooctane- 1,3,2''-trione
C26H27NO3
Acta Crystallographica Section E (2006) 62, 12 o5551-o5553
a=14.3552(8)Å b=9.9061(6)Å c=15.9692(9)Å
α=90.00° β=113.7000(10)° γ=90.00°
1'-Methyl-3',5''-diphenyl-5'',6'',7'',8'',9'',10'',11''1H-indole-3-spiro- 2'-pyrrolidine-4'-spiro-2''-cycloocteno[1,2-d]thiazolo[3,2-a]pyrimidine- 2,3''-dione
C35H34N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5554-o5556
a=10.6368(8)Å b=12.1783(9)Å c=13.1467(10)Å
α=95.2590(10)° β=109.1330(10)° γ=108.6040(10)°
1-N-methyl-spiro[2.3']oxindole-spiro[3.2'']-5''-phenyl- 5'',6'',7'',8'',9'',10''-hexahydrocyclohepteno[1,2-d]thiazolo[3,2-a]pyrimidin- 3''-one-4-(p-methyl)phenyl-pyrrolidine
C35H34N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5658-o5660
a=11.3427(8)Å b=12.0148(9)Å c=13.0102(10)Å
α=95.6040(10)° β=110.8870(10)° γ=109.5670(10)°
3''-(4-Bromobenzylidene)-4'-(4-bromophenyl)-1'-methylindan-2-spiro- 2'-pyrrolidine-3'-spiro-1''-cyclohexane-1,3,2''-trione
C31H25Br2NO3
Acta Crystallographica Section E (2006) 62, 12 o5388-o5389
a=14.3345(10)Å b=13.0061(9)Å c=14.2616(10)Å
α=90.00° β=99.2230(10)° γ=90.00°
1-N-methyl-spiro[2.3']oxindole-spiro[3.2'']-5''-phenyl- 5'',6'',7'',8'',9'',10'',11''-heptahydrocycloocteno[1,2-d]thiazolo[3,2-a] pyrimidin-3''-one-4-(p-methyl)phenyl-pyrrolidine
C36H36N4O2S
Acta Crystallographica Section E (2006) 62, 12 o5661-o5663
a=11.3531(8)Å b=12.1973(9)Å c=13.2117(9)Å
α=94.1810(10)° β=111.6830(10)° γ=111.3770(10)°
Ethyl 5-hydroxy-3-(3-methoxybenzoyl)-1',5-dimethyl-2'-oxo-4,5-dihydro-1'H- spiro[furan-2(3H),3'(2'H)-indole]-4-carboxylate
C24H25NO7
Acta Crystallographica Section E (2006) 62, 12 o5947-o5949
a=8.4860(12)Å b=22.446(3)Å c=11.5348(16)Å
α=90.00° β=90.305(2)° γ=90.00°
Voriconazole
C16H14F3N5O
Acta Crystallographica Section E (2007) 63, 2 o565-o567
a=7.5332(19)Å b=8.349(2)Å c=12.989(3)Å
α=90.00° β=100.062(4)° γ=90.00°
2-(2-Hydroxy-5-methylbenzylideneammonio)benzoate
C15H13NO3
Acta Crystallographica Section E (2007) 63, 2 o849-o851
a=22.5716(15)Å b=7.1742(4)Å c=15.4336(9)Å
α=90.00° β=97.093(2)° γ=90.00°
1'-Methylacenapthylene-1(2H)-spiro-2'-pyrrolidine-3'-spiro-2''(3''H)- carbazole-2,1''(4''H)-dione
C33H26N2O2
Acta Crystallographica Section E (2007) 63, 2 o843-o845
a=9.2279(6)Å b=21.9358(13)Å c=12.7618(8)Å
α=90.00° β=103.1630(10)° γ=90.00°
3-(3-Methoxybenzoyl)-1',6,6-trimethyl-4,5,6,7- tetrahydrospiro[benzo[b]furan-2(3H),3'(2'H)-1H-indole]-4,2'-dione
C26H25NO5
Acta Crystallographica Section E (2007) 63, 2 o846-o848
a=9.4557(8)Å b=11.7500(10)Å c=12.3946(10)Å
α=116.1680(10)° β=93.0050(10)° γ=111.9250(10)°
Methyl 6-chloro-5-[hydroxy(5-oxocyclopent-1-enyl)methyl]pyridine-2-carboxylate
C13H12ClNO4
Acta Crystallographica Section E (2007) 63, 4 o1842-o1843
a=9.6954(6)Å b=11.0961(6)Å c=12.0810(7)Å
α=90.00° β=105.6710(10)° γ=90.00°
7-Allyl-1,3-dimethyl-2,4-dioxo-2,3,4,7-tetrahydro- 1<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-6-carbaldehyde
C12H13N3O3
Acta Crystallographica Section E (2007) 63, 5 o2303-o2305
a=6.7065(4)Å b=13.1295(9)Å c=13.6977(9)Å
α=90.00° β=99.6130(10)° γ=90.00°
4-Methyl-2-[(4-nitrophenylimino)methyl]phenol
C14H12N2O3
Acta Crystallographica Section E (2007) 63, 5 o2324-o2326
a=28.698(2)Å b=6.0051(5)Å c=28.574(2)Å
α=90.00° β=92.318(2)° γ=90.00°
4'-Ferrocenyl-3'-(4-methoxybenzoyl)-1'-methylspiro[1H-indole-3(2H),2'- pyrrolidin]-2-one
C30H28FeN2O3
Acta Crystallographica Section E (2007) 63, 5 m1287-m1289
a=9.4895(5)Å b=11.4943(6)Å c=12.3633(7)Å
α=86.9780(10)° β=71.3020(10)° γ=77.8220(10)°
Epoxyazadiradione
C28H34O6
Acta Crystallographica Section E (2007) 63, 5 o2483-o2485
a=9.6532(7)Å b=12.6550(9)Å c=10.5710(8)Å
α=90.00° β=105.0960(10)° γ=90.00°
1-{2-[(Anthracen-10-yl)methyleneamino]phenyl}-3-phenylthiourea
C28H21N3S
Acta Crystallographica Section E (2008) 64, 2 o408-o408
a=6.6148(6)Å b=14.3154(12)Å c=23.823(2)Å
α=74.0450(10)° β=88.7050(10)° γ=87.4210(10)°
R-2,c-6-Bis(4-fluorophenyl)-t-3,t-5-dimethylpiperidin-4-one
C19H19F2NO
Acta Crystallographica Section E (2008) 64, 2 o429-o429
a=7.3830(6)Å b=24.0102(19)Å c=9.4278(7)Å
α=90.00° β=101.7270(10)° γ=90.00°
N-(1-Acetyl-r-7,c-9-diphenyl-4,8-dithia-1,2-diazaspiro[5.4]dec-2-en-3- yl)acetamide
C22H23N3O2S2
Acta Crystallographica Section E (2008) 64, 2 o494-o495
a=12.3310(7)Å b=16.0218(9)Å c=12.3852(7)Å
α=90.00° β=116.7140(10)° γ=90.00°
3-[(E)-4-Methoxybenzylidene]-1-methylpiperidin-4-one
C14H17NO2
Acta Crystallographica Section E (2008) 64, 3 o552
a=7.5212(7)Å b=12.4097(11)Å c=13.5062(12)Å
α=90.00° β=90.00° γ=90.00°
Erlotinib hydrochloride
C22H24N3O4,Cl
Acta Crystallographica Section E (2008) 64, 5 o931
a=14.5351(15)Å b=18.4863(19)Å c=8.1222(8)Å
α=90.00° β=102.966(2)° γ=90.00°
Donepezilium oxalate trihydrate
C24H30NO3,C2HO4,3H2O
Acta Crystallographica Section C (2006) 62, 12 o681-o683
a=8.5002(5)Å b=17.6318(10)Å c=18.2158(10)Å
α=90.00° β=97.7440(10)° γ=90.00°
(2Z)-2-benzylidene-N,7-dimethyl-3-oxo-5-phenyl- 5H-1,3-thiazolo[3,2-a]pyrimidine-6(3H)-carboxamide
C22H19N3O2S
Acta Crystallographica Section C (2006) 62, 12 o687-o690
a=9.5353(6)Å b=10.2071(6)Å c=20.7901(12)Å
α=79.1980(10)° β=79.6450(10)° γ=78.2570(10)°
(2Z)-2-benzylidene-N,7-dimethyl-3-oxo-5-phenyl- 5H-1,3-thiazolo[3,2-a]pyrimidine-6(3H)-carboxamide
C22H19N3O2S
Acta Crystallographica Section C (2006) 62, 12 o687-o690
a=5.1109(9)Å b=9.5564(16)Å c=20.503(3)Å
α=97.594(3)° β=93.371(3)° γ=101.755(3)°
Lenalidomide
C13H13N3O3
Acta Crystallographica Section C (2009) 65, 10 o502-o505
a=5.9983(5)Å b=8.9198(8)Å c=11.5785(10)Å
α=75.7110(10)° β=84.6600(10)° γ=86.0380(10)°
Lenalidomide hemihydrate
C13H13N3O3,0.5H2O
Acta Crystallographica Section C (2009) 65, 10 o502-o505
a=8.4425(7)Å b=22.2874(19)Å c=13.6627(12)Å
α=90.00° β=101.0690(10)° γ=90.00°
1-[2-(2,6-Dimethylsulfanyl-9<i>H</i>-purin-9-yl)-2-methylidenepropyl]-4,6-bis(methylsulfanyl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C18H20N8S4
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.285(4)Å b=9.818(4)Å c=13.400(6)Å
α=98.707(7)° β=103.080(3)° γ=109.593(4)°
7,7'-(2-Methylidenepropane-1,3-diyl)bis[3-methyl-2-methylsulfanyl-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4(7<i>H</i>)-one]
C20H22N6O2S2
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.859(2)Å b=13.979(4)Å c=29.331(8)Å
α=90.00° β=90.00° γ=90.00°
7-[2-(4,6-Dimethylsulfanyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-1-yl)-2-\ methylidenepropyl]-3-methyl-2-methylsulfanyl-3<i>H</i>-pyrrolo[2,3-<i>d</i>]\ pyrimidin-4(7<i>H</i>)-one
C19H21N7OS3
Acta Crystallographica Section C (2014) 70, 6 555-561
a=9.5436(7)Å b=11.5329(8)Å c=21.0042(13)Å
α=90.00° β=107.943(3)° γ=90.00°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-methoxy-2-phenylacetate
C24H28N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=16.7030(13)Å b=8.0515(6)Å c=17.0919(13)Å
α=90° β=90° γ=90°
Methyl 2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-[(4-methoxybenzyl)oxy]-2-phenylacetate
C31H34N2O7
Acta Crystallographica Section C (2015) 71, 4 322-329
a=13.9402(12)Å b=16.5380(15)Å c=14.3279(13)Å
α=90° β=116.0420(10)° γ=90°
Methyl 2-[(anthracen-9-yl)methoxy]-2-{3-[(<i>tert</i>-butoxycarbonyl)amino]-1-methyl-2-oxoindolin-3-yl}-2-phenylacetate
C38H36N2O6
Acta Crystallographica Section C (2015) 71, 4 322-329
a=18.2606(17)Å b=9.8976(9)Å c=18.5364(17)Å
α=90° β=99.310(2)° γ=90°
C31H41N1O4
C31H41N1O4
Acta Crystallographica Section C (1994) 50, 12 2089-2093
a=9.997(2)Å b=12.780(2)Å c=21.163(4)Å
α=90.° β=90.° γ=90.°
Bis(adeninium) phthalate phthalic acid 1.45-hydrate
2C5H6N5,C8H4O42,C8H6O4,1.45H2O
Acta Crystallographica Section C (2007) 63, 4 o212-o214
a=7.0100(5)Å b=33.052(2)Å c=24.2496(17)Å
α=90.00° β=90.00° γ=90.00°
6,8-dinitro-2,4-dihydro-1<i>H</i>- benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C9H5N5O6
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=6.6313(4)Å b=18.5174(11)Å c=8.3354(5)Å
α=90.00° β=91.3520(10)° γ=90.00°
(<i>E</i>)-2-(2-hydroxy-4-oxopent-2-en-3-yl)-6,8-dinitro-2,4-dihydro- 1<i>H</i>-benzo[<i>b</i>][1,2,4]triazolo[4,3-<i>d</i>][1,4]oxazin-1-one
C14H11N5O8
Acta Crystallographica Section C (2012) 68, 8 o302-o307
a=7.2636(8)Å b=17.673(2)Å c=12.0447(13)Å
α=90.00° β=90.00° γ=90.00°
Cytosine
C4H5N3O
Acta Crystallographica Section C (2015) 71, 2
a=15.1040(10)Å b=15.1212(10)Å c=9.2948(6)Å
α=90° β=90° γ=90°
Teuctosin
C22H28O8
Acta Crystallographica Section C (2003) 59, 9 o530-o532
a=7.7235(5)Å b=19.0625(9)Å c=13.8907(13)Å
α=90.00° β=90.00° γ=90.00°
Adeninium hemioxalate chloride
2(C5H7N52),C2O42,2(Cl)
Acta Crystallographica Section C (2009) 65, 5 o202-o206
a=4.3758(4)Å b=17.1354(15)Å c=11.1188(10)Å
α=90.00° β=96.558(2)° γ=90.00°
Adeninium oxalate hemioxalic acid hydrate
C5H6N5,C2HO4,0.5C2H2O4,H2O
Acta Crystallographica Section C (2009) 65, 5 o202-o206
a=3.6222(3)Å b=28.131(3)Å c=11.1101(10)Å
α=90.00° β=98.696(2)° γ=90.00°
Erlotinib hemioxalate
2(C22H24N3O4),C2O42
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.6285(8)Å b=10.2252(10)Å c=14.6525(14)Å
α=86.076(2)° β=84.925(2)° γ=70.559(2)°
Granisetron
C18H24N4O
Acta Crystallographica Section C (2010) 66, 2 m35-m39
a=13.7930(12)Å b=13.5544(12)Å c=17.9574(16)Å
α=90.00° β=90.00° γ=90.00°
Erlotinib monohydrate
C22H23N3O4,H2O
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=9.0227(10)Å b=10.4548(11)Å c=13.2014(14)Å
α=98.705(2)° β=108.738(2)° γ=111.873(2)°
Erlotinib fumaric acid hemisolvate dihydrate
C22H23N3O4,0.5(C4H4O4),2(H2O)
Acta Crystallographica Section C (2010) 66, 1 o33-o38
a=7.967(2)Å b=13.248(4)Å c=13.745(4)Å
α=108.916(5)° β=106.673(5)° γ=101.909(5)°
Diaqua[1-methyl-<i>N</i>-(9-methyl-9-azoniabicyclo[3.3.1]nonan-7-yl)indazole- 3-carboxamide]cobalt(II) tetrachloride dodecahydrate
C36H54CoN8O44,4(Cl),12(H2O)
Acta Crystallographica Section C (2010) 66, 2 m35-m39
a=9.6311(9)Å b=9.9794(9)Å c=16.0133(14)Å
α=92.6110(10)° β=103.4490(10)° γ=118.0370(10)°